Frequently Asked Questions
Common Questions About Using ICD-10 Code E71.440 for Ruvalcaba-Myhre-Smith syndrome
What are the common symptoms of Ruvalcaba-Myhre-Smith syndrome?
Common symptoms include skeletal abnormalities, intellectual disability, and distinctive facial features. Patients may also experience developmental delays and require multidisciplinary care.
How is Ruvalcaba-Myhre-Smith syndrome diagnosed?
Diagnosis is typically made through clinical evaluation, family history, and genetic testing to identify mutations in the KMT2A gene.
What treatment options are available for Ruvalcaba-Myhre-Smith syndrome?
Treatment focuses on supportive care, including physical, occupational, and speech therapy, tailored to the individual needs of the patient.
Is Ruvalcaba-Myhre-Smith syndrome hereditary?
Yes, Ruvalcaba-Myhre-Smith syndrome is a genetic disorder caused by mutations in the KMT2A gene, which can be inherited from affected parents.
